MY100602A - Substituted spiro pyridine derivatives, pharmaceutical composition containing them and processes for the preparation of such compounds and compositions - Google Patents
Substituted spiro pyridine derivatives, pharmaceutical composition containing them and processes for the preparation of such compounds and compositionsInfo
- Publication number
- MY100602A MY100602A MYPI87001838A MYPI19871838A MY100602A MY 100602 A MY100602 A MY 100602A MY PI87001838 A MYPI87001838 A MY PI87001838A MY PI19871838 A MYPI19871838 A MY PI19871838A MY 100602 A MY100602 A MY 100602A
- Authority
- MY
- Malaysia
- Prior art keywords
- compositions
- compounds
- processes
- preparation
- pharmaceutical composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Chemical class 0.000 title 1
- -1 spiro pyridine derivatives Chemical class 0.000 title 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/561,416 US4652564A (en) | 1983-12-14 | 1983-12-14 | Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents |
| US06/641,076 US4632923A (en) | 1984-08-15 | 1984-08-15 | Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY100602A true MY100602A (en) | 1990-12-15 |
Family
ID=27072640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI87001838A MY100602A (en) | 1983-12-14 | 1987-09-22 | Substituted spiro pyridine derivatives, pharmaceutical composition containing them and processes for the preparation of such compounds and compositions |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0144996B1 (pt) |
| JP (1) | JPH066586B2 (pt) |
| KR (1) | KR900004832B1 (pt) |
| AU (1) | AU574749B2 (pt) |
| CA (1) | CA1252786A (pt) |
| DE (1) | DE3481418D1 (pt) |
| DK (1) | DK169721B1 (pt) |
| FI (1) | FI79539C (pt) |
| GB (1) | GB2153348B (pt) |
| GR (1) | GR82463B (pt) |
| HK (1) | HK48890A (pt) |
| HU (1) | HU193913B (pt) |
| IL (1) | IL73823A (pt) |
| MY (1) | MY100602A (pt) |
| NO (1) | NO163896C (pt) |
| NZ (1) | NZ210551A (pt) |
| OA (1) | OA07899A (pt) |
| PT (1) | PT79672A (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1261754A (en) * | 1985-06-18 | 1989-09-26 | Sidney R. Smith | Pharmaceutical compositions containing azanaphthalenes |
| ATE90096T1 (de) * | 1986-04-11 | 1993-06-15 | Schering Corp | Arylsubstituierte naphthyridin- und pyridopyrazin-derivate. |
| US5045542A (en) * | 1986-10-20 | 1991-09-03 | Schering Corporation | Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives |
| US5350755A (en) * | 1986-12-05 | 1994-09-27 | Schering Corporation | Compounds and methods for treating hyperproliferative skin disease |
| CA1309658C (en) * | 1986-12-05 | 1992-11-03 | David J. Blythin | Pharmaceutical compositions for treatment of hyperproliferate skin disease |
| JP2003505388A (ja) | 1999-07-21 | 2003-02-12 | アストラゼネカ・アクチエボラーグ | 新規化合物 |
| US7592457B2 (en) * | 2004-10-20 | 2009-09-22 | Korea Research Institute Of Chemical Technology | 3-aryl-3-methyl-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB855022A (en) * | 1957-08-06 | 1960-11-30 | Geigy Ag J R | Improvements in and relating to carbostyril derivatives |
| JPS5089376A (pt) * | 1973-12-19 | 1975-07-17 | ||
| US4215216A (en) * | 1979-04-18 | 1980-07-29 | American Home Products Corporation | 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives |
| EP0092786B1 (en) * | 1982-04-26 | 1987-01-07 | Schering Corporation | 1,8-naphthyridine and 1,5,8-azanaphthyridine derivatives |
-
1984
- 1984-12-08 EP EP84114974A patent/EP0144996B1/en not_active Expired - Lifetime
- 1984-12-08 DE DE8484114974T patent/DE3481418D1/de not_active Expired - Lifetime
- 1984-12-11 JP JP59261664A patent/JPH066586B2/ja not_active Expired - Lifetime
- 1984-12-13 KR KR1019840007885A patent/KR900004832B1/ko not_active Expired
- 1984-12-13 CA CA000470037A patent/CA1252786A/en not_active Expired
- 1984-12-13 PT PT79672A patent/PT79672A/pt not_active IP Right Cessation
- 1984-12-13 GR GR82463A patent/GR82463B/el unknown
- 1984-12-13 NZ NZ210551A patent/NZ210551A/en unknown
- 1984-12-13 HU HU844651A patent/HU193913B/hu not_active IP Right Cessation
- 1984-12-13 GB GB08431542A patent/GB2153348B/en not_active Expired
- 1984-12-13 DK DK597184A patent/DK169721B1/da not_active IP Right Cessation
- 1984-12-13 AU AU36624/84A patent/AU574749B2/en not_active Ceased
- 1984-12-13 NO NO845016A patent/NO163896C/no unknown
- 1984-12-13 FI FI844919A patent/FI79539C/fi not_active IP Right Cessation
- 1984-12-14 IL IL73823A patent/IL73823A/xx not_active IP Right Cessation
- 1984-12-14 OA OA58476A patent/OA07899A/xx unknown
-
1987
- 1987-09-22 MY MYPI87001838A patent/MY100602A/en unknown
-
1990
- 1990-06-21 HK HK488/90A patent/HK48890A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI844919L (fi) | 1985-06-15 |
| DK597184D0 (da) | 1984-12-13 |
| HUT36477A (en) | 1985-09-30 |
| DK597184A (da) | 1985-06-15 |
| KR900004832B1 (ko) | 1990-07-07 |
| AU3662484A (en) | 1985-06-20 |
| NZ210551A (en) | 1988-05-30 |
| IL73823A0 (en) | 1985-03-31 |
| GB8431542D0 (en) | 1985-01-23 |
| GB2153348A (en) | 1985-08-21 |
| HU193913B (en) | 1987-12-28 |
| AU574749B2 (en) | 1988-07-14 |
| IL73823A (en) | 1988-03-31 |
| DE3481418D1 (de) | 1990-04-05 |
| JPS60156689A (ja) | 1985-08-16 |
| KR850004487A (ko) | 1985-07-15 |
| GR82463B (en) | 1985-04-16 |
| FI844919A0 (fi) | 1984-12-13 |
| NO163896C (no) | 1990-08-08 |
| GB2153348B (en) | 1987-08-12 |
| JPH066586B2 (ja) | 1994-01-26 |
| NO845016L (no) | 1985-06-17 |
| HK48890A (en) | 1990-06-29 |
| EP0144996A3 (en) | 1986-06-11 |
| NO163896B (no) | 1990-04-30 |
| OA07899A (fr) | 1986-11-20 |
| PT79672A (en) | 1985-01-01 |
| EP0144996B1 (en) | 1990-02-28 |
| EP0144996A2 (en) | 1985-06-19 |
| FI79539C (fi) | 1990-01-10 |
| DK169721B1 (da) | 1995-01-23 |
| FI79539B (fi) | 1989-09-29 |
| CA1252786A (en) | 1989-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT78703A (en) | Process for preparing novel aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents and of pharmaceutical compositions containing the same | |
| IL76839A (en) | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| EP0167919A3 (en) | Benzodiazepine derivatives and pharmaceutical compositions containing them | |
| GB2126226B (en) | Pyridine derivatives | |
| IL76454A (en) | Diarylacetylene derivatives,their preparation and pharmaceutical compositions containing them | |
| SE8500460D0 (sv) | Nya 6-substituerade furo-(3,4-c)-pyridin-derivat, sett for deras framstellning och terapeutiska kompositioner, innehallande foreningarna | |
| ES8600299A1 (es) | Procedimiento para preparar derivados de 1, 3-dihidro-6-vinil-7-hidroxifuro-(3, 4-c)-piridina | |
| IL76175A0 (en) | Tricyclic oxindole derivatives and pharmaceutical compositions containing them | |
| ZA849734B (en) | Substituted spiro pyridine derivatives pharmaceutical compositions containing them and process for the preparation of such compounds and compositions | |
| CA2016551A1 (en) | Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them | |
| PT84713A (en) | Process for the preparation of novel substituted n-phenyl (thio)ureas and functional derivatives thereof of pesticide compositions containing the same and of intermediate compounds useful for their preparation | |
| IL75638A0 (en) | Aryl derivatives of heterobicyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL73823A0 (en) | Substituted spiro pyridine derivatives,pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions | |
| DE3163536D1 (en) | Pharmaceutical compositions containing two beta-lactam derivatives | |
| PT85378A (en) | Process for the preparation of new tetracyclic indole derivatives and of pharmaceutical compositions containing the same | |
| PT77946A (en) | Process for preparing substituted carboxi-thiazolo<3,2-a>pyrimidine derivatives and of pharmaceutical compositions containing the same | |
| EP0055907A3 (en) | Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor | |
| IL77139A0 (en) | Nitrogen derivatives of oxo compounds,their manufacture and pharmaceutical compositions containing them | |
| IL90172A0 (en) | 2,3-dihydro-imidazo(1,2-a)furo and-thieno pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| KE3579A (en) | Pharmaceutical compositions containing two beta-lactam derivatives |